BioSpace News Archive

Puma Biotechnology, Inc. announced that its licensing partner in Greater China, CANbridge Pharmaceuticals Inc., has received registration approval from the Department of Health in Hong Kong to market NERLYNX® for the extended adjuvant treatment of adult patients with early stage hormone receptor positive HER2-overexpressed/amplified breast cancer and who have completed adjuvant trastuzumab-based therapy less than one year ago.

Zymeworks Inc., a clinical-stage biopharmaceutical company developing multifunctional therapeutics, reported financial results for the third quarter ended September 30, 2019.

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, announced that senior management will present at the Credit Suisse 28th Annual Healthcare Conference on Tuesday, Nov. 12, 2019 at 11:10 a.m. E.T. / 9:10 a.m. M.T.

Conference Call Scheduled for November 6 at 9:00 am ET

ERYTECH is a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells

Credit Suisse 28th Annual Healthcare Conference – Presenting on Tuesday, November 12, at 10:00 AM ET (8:00 AM MT)

The translates to 200,000 fewer deaths in 2016 than if mortality rates stayed the same as 2009.

Bringing 40 years of healthcare expertise and a fast growing network of quality care providers

Ironwood Pharmaceuticals, Inc. will present a corporate update at the 28th Annual Credit Suisse Healthcare Conference on Tuesday, November 12, 2019 at 4:10 p.m.

Urovant Sciences, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, reported financial results for the 2019 second fiscal quarter ended September 30, 2019.